Jiangxi: Encourage commercial health insurance companies to provide stable long-term investment for the research and development of innovative drugs through various means.

date
03/12/2025
The General Office of the People's Government of Jiangxi Province has issued the "Implementation Opinions on Comprehensive Deepening of Drug, Medical Device, and Cosmetics Regulation Reform to Promote the High-Quality Development of the Pharmaceutical Industry." In it, it proposes to support the entry of innovative drugs and medical devices into relevant catalogs. It guides innovative drug and medical device enterprises in the province to participate in the application for innovative drugs and national medical insurance negotiation drugs, supports the entry of innovative drugs in Jiangxi Province into the national medical insurance drug catalog or commercial insurance drug catalog, and supports the entry of innovative medical devices into the medical consumables catalog. It will improve the dynamic adjustment mechanism of the basic medical insurance drug catalog and medical consumables catalog. It encourages commercial health insurance companies to provide stable and long-term investment for innovative drug research and development through various means.